Literature DB >> 25083490

Oncoplastic technique in breast conservative surgery for locally advanced breast cancer.

Prakasit Chirappapha1, Youwanush Kongdan1, Wichai Vassanasiri1, Kampol Ratchaworapong1, Thongchai Sukarayothin1, Chairat Supsamutchai1, Phatarachate Klaiklern1, Monchai Leesombatpaiboon1, Alaa Hamza1, Stefano Zurrida1.   

Abstract

Locally advanced breast cancer (LABC) should be taken into decision making when planning breast conservative surgery, but this procedure should be done on the principle of oncologic safety in order to achieve negative surgical margin and maintain aesthetic result. This procedure should be offered as the choice of treatment in selected patients.

Entities:  

Keywords:  Breast conservative surgery; locally advanced breast cancer (LABC); neoadjuvant chemotherapy

Year:  2014        PMID： 25083490      PMCID： PMC4115767          DOI： 10.3978/j.issn.2227-684X.2014.01.01

Source DB:  PubMed          Journal:  Gland Surg        ISSN： 2227-684X


  11 in total

1.  Review of breast MRI: indications and limitations.

Authors:  E A Morris
Journal:  Semin Roentgenol       Date:  2001-07       Impact factor: 0.800

Review 2.  Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials.

Authors:  M Clarke; R Collins; S Darby; C Davies; P Elphinstone; V Evans; J Godwin; R Gray; C Hicks; S James; E MacKinnon; P McGale; T McHugh; R Peto; C Taylor; Y Wang
Journal:  Lancet       Date:  2005-12-17       Impact factor: 79.321

3.  Feasibility of breast-conservation surgery after induction chemotherapy for locally advanced breast carcinoma.

Authors:  S E Singletary; M D McNeese; G N Hortobagyi
Journal:  Cancer       Date:  1992-06-01       Impact factor: 6.860

4.  Results of a conservative treatment combining induction (neoadjuvant) and consolidation chemotherapy, hormonotherapy, and external and interstitial irradiation in 98 patients with locally advanced breast cancer (IIIA-IIIB).

Authors:  C Jacquillat; F Baillet; M Weil; G Auclerc; M Housset; M Auclerc; M Sellami; A Jindani; L Thill; C Soubrane
Journal:  Cancer       Date:  1988-05-15       Impact factor: 6.860

5.  Improving breast cancer surgery: a classification and quadrant per quadrant atlas for oncoplastic surgery.

Authors:  Krishna B Clough; Gabriel J Kaufman; Claude Nos; Ines Buccimazza; Isabelle M Sarfati
Journal:  Ann Surg Oncol       Date:  2010-02-06       Impact factor: 5.344

6.  Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18.

Authors:  N Wolmark; J Wang; E Mamounas; J Bryant; B Fisher
Journal:  J Natl Cancer Inst Monogr       Date:  2001

7.  Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902.

Authors:  J A van der Hage; C J van de Velde; J P Julien; M Tubiana-Hulin; C Vandervelden; L Duchateau
Journal:  J Clin Oncol       Date:  2001-11-15       Impact factor: 44.544

8.  Cosmetic sequelae after conservative treatment for breast cancer: classification and results of surgical correction.

Authors:  K B Clough; J Cuminet; A Fitoussi; C Nos; V Mosseri
Journal:  Ann Plast Surg       Date:  1998-11       Impact factor: 1.539

9.  Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer.

Authors:  Bernard Fisher; Stewart Anderson; John Bryant; Richard G Margolese; Melvin Deutsch; Edwin R Fisher; Jong-Hyeon Jeong; Norman Wolmark
Journal:  N Engl J Med       Date:  2002-10-17       Impact factor: 91.245

10.  Long-term outcome of neoadjuvant therapy for locally advanced breast carcinoma: effective clinical downstaging allows breast preservation and predicts outstanding local control and survival.

Authors:  William G Cance; Lisa A Carey; Benjamin F Calvo; Carolyn Sartor; Lynda Sawyer; Dominic T Moore; Julian Rosenman; David W Ollila; Mark Graham
Journal:  Ann Surg       Date:  2002-09       Impact factor: 12.969
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.